When the acute phase of COVID-19 began to fade from headlines, millions of people quietly found themselves trapped in a second, more mysterious battle. Weeks turned into months. Months into years. The virus had technically left their bodies — but the symptoms remained.

Crushing fatigue. Brain fog. Dizziness. Heart palpitations. A strange intolerance to exertion. For some, even light or sound became unbearable.

Now, a growing group of scientists believe a hidden culprit may be circulating through the bloodstream of many Long COVID patients: sticky microclots — tiny, abnormal clumps of misfolded proteins that may be disrupting oxygen flow and triggering ongoing inflammation.

What Are Microclots?

Under normal circumstances, your blood operates with remarkable precision. When you’re injured, a protein called fibrinogen transforms into fibrin, forming a mesh-like structure that stops bleeding. Once healing is complete, the body dissolves the clot.

But researchers such as Resia Pretorius and Douglas Kell have identified something unusual in some COVID and Long COVID patients: dense, resistant clots that do not break down normally.

Instead of delicate, spaghetti-like strands under a microscope, these clots appear thick, matted, and compact. Chemically, they resemble amyloids — misfolded protein structures more commonly associated with neurodegenerative conditions.

These microclots appear unusually resistant to the body’s natural clot-dissolving processes. Some studies suggest they may contain inflammatory molecules and possibly bind to viral fragments such as spike protein components. In Long COVID patients, they have been reported as both more abundant and larger than in healthy individuals.

The hypothesis is that these microscopic obstructions impair microcirculation — the vast capillary networks responsible for delivering oxygen to tissues. Even subtle disruption across millions of tiny vessels could potentially explain a wide array of symptoms.

The Immune System’s Web: NETs and the Inflammatory Loop

Recent research has added another important layer to this picture: neutrophil extracellular traps, or NETs.

NETs are web-like structures composed of DNA and enzymes released by neutrophils during a specialized immune response called NETosis. Their purpose is defensive — to trap and neutralize invading pathogens.

But when NET production becomes excessive, the system shifts from protective to pathological.

Scientists have observed that in Long COVID patients, microclots appear structurally intertwined with NETs. These interactions may create larger, denser, and more persistent clot formations. In this scenario, NETs do not merely accompany microclots — they may stabilize them.

This interaction suggests a self-perpetuating cycle. Inflammation promotes clot formation. Clotting, in turn, promotes more inflammation. When the feedback loop fails to switch off, chronic symptoms may follow.

Where the Trouble May Begin

To understand why this matters, we need to look at the endothelium — the thin cellular lining of blood vessels.

COVID-19 has increasingly been understood as a vascular disease as much as a respiratory one. The virus can affect endothelial cells, leading to inflammation and dysfunction. When the endothelium becomes activated, it shifts into a pro-clotting state. Platelets become hyperactive. Fibrin production increases. Blood becomes more prone to coagulation.

In severe COVID cases, widespread clotting has been clearly documented. The unresolved question is whether a subtler version of endothelial dysfunction persists in some individuals, contributing to Long COVID.

If microclots are partially obstructing capillaries, tissues may receive less oxygen than they require — not enough to cause organ failure, but enough to impair normal function. Organs with high energy demands, such as the brain, heart, and skeletal muscles, are particularly vulnerable to even slight reductions in oxygen delivery.

Key Symptoms to Watch For

Long COVID is known for its broad and sometimes bewildering range of symptoms. Many of them are consistent with impaired microvascular circulation and ongoing inflammation. While experiences vary from person to person, commonly reported symptoms include:

Neurological Symptoms

• Brain fog
• Difficulty concentrating
• Memory problems
• Headaches
• Dizziness or vertigo
• Sensitivity to light and sound

Cardiovascular Symptoms

• Heart palpitations
• Chest tightness
• Exercise intolerance
• Rapid heart rate upon standing (POTS-like symptoms)

Respiratory Symptoms

• Shortness of breath
• Air hunger
• Reduced stamina during physical activity

Musculoskeletal Symptoms

• Muscle pain
• Joint discomfort
• Post-exertional malaise (symptom worsening after activity)
• Profound, persistent fatigue

Systemic and Inflammatory Symptoms

• Fluctuating symptom severity
• Signs of ongoing inflammation
• Autoimmune-like reactions

It is important to emphasize that not every Long COVID patient has documented microclots, and not every microclot necessarily causes symptoms. But the overlap between microvascular dysfunction and reported experiences is significant enough to warrant serious scientific attention.

Can Dissolving Clots Reverse Long COVID?

Where a mechanism is proposed, treatments inevitably follow.

Some clinicians have experimented with anticoagulants, antiplatelet therapies, or combinations sometimes referred to as “triple therapy.” Others have explored forms of apheresis — procedures that filter blood to remove certain proteins or inflammatory components.

A number of patients report improvements in fatigue, cognition, and cardiovascular symptoms following such treatments. However, the evidence base remains limited, and large randomized controlled trials are still lacking.

Blood thinners carry real risks, including dangerous bleeding. Without rigorous clinical trials, it is impossible to determine whether improvements are due to the therapy itself, placebo effects, or the natural course of recovery.

Major reviews and research bodies currently advise caution and recommend that such interventions be confined to clinical studies until stronger evidence emerges. The scientific community remains divided — not over whether Long COVID is real, but over whether microclots are the central driver or one piece of a much larger puzzle.

The Future of Post-Viral Medicine

For decades, post-viral syndromes and chronic fatigue conditions were often dismissed due to the absence of clear structural abnormalities. Standard laboratory tests frequently return within normal ranges. Imaging scans may show little to explain profound disability.

Long COVID is challenging that framework.

Advanced imaging techniques, biomarker analysis, and machine learning tools are revealing subtle physiological changes that traditional diagnostics might miss. The concept of microclots — whether ultimately validated as central or secondary — has helped move the conversation forward. It suggests that “invisible” illnesses may involve disruptions at scales too small for conventional tools to detect.

This has implications far beyond COVID-19. It invites a rethinking of how chronic inflammatory and post-viral conditions are studied and understood.

Restoring Flow in a System Out of Balance

The microclot hypothesis remains under active investigation. Evidence suggests that unusual clot-like structures and immune webs are present in at least a subset of Long COVID patients. There are plausible biological mechanisms linking endothelial dysfunction, inflammation, NET formation, and impaired microcirculation. At the same time, definitive causal proof is still lacking, and treatments targeting clotting pathways require careful, controlled study.

What is undeniable is the lived reality of millions experiencing persistent symptoms after infection. The search for answers is not abstract — it is urgent.

Long COVID may ultimately prove to be a multi-layered condition in which immune dysregulation, vascular disturbance, and metabolic stress intersect. Microclots could represent one visible manifestation of a system struggling to return to equilibrium.

Health depends on flow — of oxygen, nutrients, immune signals, and energy. When that flow becomes obstructed, even microscopically, the effects can ripple outward into every aspect of human experience.

Whether microclots are the central cause or one part of a larger cascade, their study reflects a broader shift in medicine toward understanding chronic illness as dynamic, systemic, and deeply interconnected. As research continues, the goal is not simply to dissolve clots, but to restore balance — and with it, the possibility of full recovery.

Loading...